Oscar Health Second Quarter 2025 Earnings: Revenues Disappoint

5 months ago

Skip to navigation Skip to main content Skip to right column

Mon, Aug 11, 2025, 8:42 AM 1 min read

In This Article:

Explore Oscar Health's Fair Values from the Community and select yours

Revenue: US$2.86b (up 29% from 2Q 2024).
Net loss: US$228.4m (down from US$56.2m profit in 2Q 2024).
US$0.89 loss per share (down from US$0.23 profit in 2Q 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) was mostly in line with analyst estimates.

Looking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in the US.

Performance of the American Insurance industry.

The company's shares are up 12% from a week ago.

It is worth noting though that we have found 2 warning signs for Oscar Health that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Source health rss

↑